Chemical Works of Gedeon Richter (BUD:RICHTER) Other Operating Expense : Ft72,203 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Chemical Works of Gedeon Richter Other Operating Expense?

Chemical Works of Gedeon Richter's Other Operating Expense for the three months ended in Dec. 2023 was Ft38,055 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was Ft72,203 Mil.

Chemical Works of Gedeon Richter's quarterly Other Operating Expense increased from Jun. 2023 (Ft-12,229 Mil) to Sep. 2023 (Ft39,518 Mil) but then declined from Sep. 2023 (Ft39,518 Mil) to Dec. 2023 (Ft38,055 Mil).

Chemical Works of Gedeon Richter's annual Other Operating Expense increased from Dec. 2021 (Ft9,493 Mil) to Dec. 2022 (Ft51,014 Mil) and increased from Dec. 2022 (Ft51,014 Mil) to Dec. 2023 (Ft56,544 Mil).

Chemical Works of Gedeon Richter Other Operating Expense Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Other Operating Expense Chart

Chemical Works of Gedeon Richter Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

17,267.00

9,493.00

51,014.00

56,544.00

Chemical Works of Gedeon Richter Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															48,555.00	6,859.00	-12,229.00	39,518.00	38,055.00

Chemical Works of Gedeon Richter Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft72,203 Mil.

Chemical Works of Gedeon Richter Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

RGEDF:USA GEDSF:USA 0QFP:UK RIG2:Germany

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.richter.hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines